cystine/zhubný nádor

Odkaz sa uloží do schránky

Vyberte typ zoradenia

11 výsledky

Anti-transplanted tumor remedy

Články môžu prekladať iba registrovaní používatelia

Prihlásiť Registrácia

It is a purpose of this invention to create a cytostatic composition for treatment of transplanted tumors in animals by structurally combining antimetabolics (the hydrazide of cystine and of cysteine, respectively) with an alkylating group. In connection with the invention, U.S. Pat. No. 3,897,494,

Combination and method of treatment of cancer utilizing a COX-2 inhibitor and a 3-hydroxy-3-methylglutaryl-coenzyme-a (HMG-CoA) reductase inhibitor

Články môžu prekladať iba registrovaní používatelia

Prihlásiť Registrácia

SUMMARY OF INVENTION The inventors propose a combination of an HMG-CoA reductase inhibitor (also referred to as "HMG-CoA inhibitor(s)"), and COX-2 inhibitor for the treatment of cancer especially prostate cancer and a method of treatment of cancer by that combination, especially prostate cancer. The

Methods and compositions for treating cancer

Články môžu prekladať iba registrovaní používatelia

Prihlásiť Registrácia

BACKGROUND OF THE INVENTION Apoptosis, or programmed cell death, is a naturally occurring process that has been strongly conserved during evolution to prevent uncontrolled cell proliferation. This form of cell suicide plays a critical role in ensuring the development and maintenance of multicellular

Platinum bound to transferrin for use in the treatment of breast tumors

Články môžu prekladať iba registrovaní používatelia

Prihlásiť Registrácia

BACKGROUND OF THE INVENTION Transferrin is a protein found in the blood of all humans and its known function is to carry iron to those organs and cells of the body that require this metal for normal function. Recently, scientists have reported that an important function of iron carried by

Engineered primate cystine/cysteine degrading enzymes as antineogenic agents

Články môžu prekladať iba registrovaní používatelia

Prihlásiť Registrácia

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates generally to the fields of medicine and biology. More particularly, it concerns compositions and methods for the treatment of cancer with enzymes that deplete both L-cystine and L-cysteine. Even more particularly, it

Engineered primate cystine/cysteine degrading enzymes as antineogenic agents

Články môžu prekladať iba registrovaní používatelia

Prihlásiť Registrácia

Cystine knot peptides that bind alpha-V-beta-6 integrin

Články môžu prekladať iba registrovaní používatelia

Prihlásiť Registrácia

REFERENCE TO SEQUENCE LISTING, COMPUTER PROGRAM, OR COMPACT DISK In accordance with "Legal Framework for EFS-Web," (2006 Apr. 11) submit herewith is a sequence listing as an ASCII text file. The text file will serve as both the paper copy required by 37 CFR 1.821(c) and the computer readable form

Targeted liposomes in cancer therapy

Články môžu prekladať iba registrovaní používatelia

Prihlásiť Registrácia

FIELD OF THE INVENTION The invention relates to compositions and methods for the targeted delivery of therapeutic and diagnostic agents, including targeted intracellular delivery therapeutic and diagnostic agents, and to the treatment of hyperproliferative diseases. BACKGROUND The effectiveness of

Protein ACA1 of Antrodia camphorata

Články môžu prekladať iba registrovaní používatelia

Prihlásiť Registrácia

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a protein, named ACA1, purified from Antrodia camphorata, and more particularly to the amino acid sequence of ACA1 and its immunomodulatory activity, as demonstrated by its stimulatory activity toward RAW 264.7

Methods for treating glioma

Články môžu prekladať iba registrovaní používatelia

Prihlásiť Registrácia

FIELD OF THE DISCLOSURE The present disclosure relates generally to the treatment and or prevention of a diseases state that required cystine for maintenance of progression of the disease state. More specifically, the present disclosure relates to the treatment and prevention of glioma via the

Antitumor substance

Články môžu prekladať iba registrovaní používatelia

Prihlásiť Registrácia

BACKGROUND OF THE INVENTION 1. Field of the Invention This invention relates to a new antitumor substance and, in particular, relates to a new substance having antitumor activity against certain types of tumors and containing protein, which substance is obtained from an epidermal portion of rice. 2.

Pripojte sa k našej
facebookovej stránke

Herbal & Natural Medicine

Najkompletnejšia databáza liečivých bylín podporovaná vedou

Pracuje v 55 jazykoch
Bylinné lieky podporené vedou
Rozpoznávanie bylín podľa obrázka
Interaktívna GPS mapa - označte byliny na mieste (už čoskoro)
Prečítajte si vedecké publikácie týkajúce sa vášho hľadania
Vyhľadajte liečivé byliny podľa ich účinkov
Usporiadajte svoje záujmy a držte krok s novinkami, klinickými skúškami a patentmi

Zadajte príznak alebo chorobu a prečítajte si o bylinách, ktoré by vám mohli pomôcť, napíšte bylinu a pozrite sa na choroby a príznaky, proti ktorým sa používa.
* Všetky informácie sú založené na publikovanom vedeckom výskume